GEMINI THERAPEUTICS INC (GMTX)

US36870G1058 - Common Stock

1.35  0 (0%)

After market: 1.32 -0.03 (-2.22%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.00
Operating Expenses
42.19M68.70M810.00KN/A
Research and Development
24.46M48.62MN/AN/A
Selling, General, and Administrative Expenses
17.73M20.09M820.00KN/A
Operating Income
-42.19M-68.70M-810.00K0.00
Interest Income/Expense
421.00K-2.14MN/AN/A
Other Income/Expense
48.00K-13.00KN/AN/A
Non Recurring Items
-1.70M-1.01MN/AN/A
Income Before Taxes
-43.42M-71.87M-810.00KN/A
Income Tax
N/AN/A0.00N/A
Net Income
-43.42M-71.87M-810.00KN/A
EBITDA
N/A-68.47MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-1.01-1.78-0.05N/A
Non GAAP EPS
N/A-1.81N/AN/A
 
Statistics

All data in USD

Charts